Adam Crystal Tango Therapeutics, Inc. (TNGX) insider trading activity

TNGX Quotes by TradingView

Adam Crystal is of Tango Therapeutics, Inc.. Currently has a direct ownership of 119,478 shares of TNGX, which is worth approximately $616,506. The most recent transaction as insider was on Feb 07, 2024, when has been sold 4,083 shares (Common Stock) at a price of $12.62 per share, resulting in proceeds of $51,527. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 119K
0% 3M change
47.05% 12M change
Total Value Held $616,506

Adam Crystal Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 07 2024
SELL
Open market or private sale
$51,527 $12.62 p/Share
4,083 Reduced 3.3%
119,478 Common Stock
Feb 06 2024
SELL
Open market or private sale
$53,857 $12.56 p/Share
4,288 Reduced 3.35%
123,561 Common Stock
Feb 01 2024
BUY
Grant, award, or other acquisition
-
46,599 Added 50.0%
46,599 Common Stock
Nov 01 2023
SELL
Open market or private sale
$62,983 $8.39 p/Share
7,507 Reduced 8.46%
81,250 Common Stock
Mar 01 2023
BUY
Grant, award, or other acquisition
-
81,250 Added 50.0%
81,250 Common Stock

Also insider at

CCCC
C4 Therapeutics, Inc. Healthcare
Chief Medical Officer
AC

Adam Crystal

Watertown, MA

Track Institutional and Insider Activities on TNGX

Follow Tango Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TNGX shares.

Notify only if

Insider Trading

Get notified when an Tango Therapeutics, Inc. insider buys or sells TNGX shares.

Notify only if

News

Receive news related to Tango Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on TNGX